Engineers Gate Manager LP Pds Biotechnology Corp Transaction History

Engineers Gate Manager LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.95 - $6.58 $75,346 - $125,513	19,075 New	19,075 $94,000
Q1 2022 May 16, 2022	SELL	$4.78 - $8.43 $83,382 - $147,052	-17,444 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $32,048 - $59,265	4,130 Added 31.02%	17,444 $141,000
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $124,219 - $227,403	13,314 New	13,314 $198,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $46.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.